Study of asthma inflammation and diet effects
Part of Immune system & allergy, Lungs & breathing clinical trials.
This early-phase study looks at how asthma-related inflammation works and whether a diet-related approach could help. It may be most relevant if you have confirmed asthma and can follow the study’s diet requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have asthma diagnosed by a specialist or test results that support asthma (like response to methacholine or breathing medicine).
- Your lung function test (FEV1) is within the study’s acceptable range.
- You can give informed consent to join the study.
- You do not have diabetes with fasting blood sugar above 110 mg/dL.
- You do not have milk or coconut allergies, and you can stick to the study diet plan.
- You are not a current smoker, and you have not smoked more than 10 pack-years in the past.
- You do not have major other health problems that could interfere (for example, serious heart or kidney disease that is not controlled).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a 12-week vegan diet can improve inflammation and immune function in people with asthma. It may help understand if plant-based eating can reduce asthma symptoms.
This study tests whether a specially designed diet plan can help adults whose asthma is not well controlled. You will use a smartphone app to track your food and symptoms, and the study will provide dietary guidance.
This study follows people with moderate-to-severe asthma and repeatedly checks how their lungs and symptoms relate to environmental exposures over time. It may help researchers better understand what triggers asthma and how exposures affect asthma control.
This Phase 2 study tests anti-inflammatory lipid mediators in people with asthma. You may be eligible if your asthma is not well controlled despite regular inhaler use and you meet the specific lung function and health criteria.
This Phase 1 study looks at how the immune system drives allergic airway inflammation in people with allergic asthma, and compares them with allergic non-asthma and non-allergic healthy volunteers. The goal is to identify immune “signals” and cell “receptors” involved, which may guide better future treatments.
This study looks at how weight and blood-sugar/fat changes in the body may affect the airways in people with asthma. You may be asked to complete breathing tests and possibly an airway procedure (bronchoscopy) to help researchers compare groups.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.